Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guava leaves extract mouthwash is an investigational botanical antimicrobial agent developed by Cairo University for the prevention and management of dental caries, particularly in high-risk patients. The formulation is derived from the leaves of the *Psidium guajava* plant and contains a complex mixture of bioactive compounds, including flavonoids (such as guaijaverin), tannins, phenolic acids, and antioxidants. Its primary mechanism of action involves the inhibition of *Streptococcus mutans*, the key bacterial species responsible for the initiation and progression of tooth decay. In clinical evaluations (NCT03773094), the mouthwash has demonstrated antibacterial efficacy comparable to the gold-standard chlorhexidine, while also being assessed for its impact on salivary pH and patient acceptability regarding taste.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guava leaves extract mouthwash.